If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOrigin Regulatory News (OGN)

Share Price Information for Origin (OGN)

Share Price is delayed by 15 minutes
Get Live Data
365.00    0.00 (0.00%)
Bid:
360.00
Ask:
370.00
Spread: 10.00 (2.778%)
Market Cap: £392.33m
OGN Live PriceLast checked at - London Stock Exchange

Intraday Origin Share Chart

Directorate Update

1 Oct 2018 16:59

RNS Number : 5966C
Origin Enterprises Plc
01 October 2018
 

 

Directorate Update

1 October 2018

 

Origin Enterprises plc ('Origin' or the 'Company') announces the appointment of Sean Coyle (45) to the Board of the Company with effect from today 1 October 2018, as previously outlined in the regulatory announcements of 7 June 2018 and 26 September 2018. Sean was appointed Chief Financial Officer on 1 September 2018.

 

Full details of his current and past directorships within the last five years are outlined below. None of these entities have any relationship with Origin Enterprises plc.

 

There are no other items requiring disclosure in accordance with Schedule 2(g) of the AIM Rules for Companies or the ESM Rules for Companies. Sean Coyle currently has an interest in 7,000 ordinary shares in Origin.

 

Current Directorships

 

None

 

Past Directorships

Sean Gerard Coyle was a director or partner of the following within the last five years:

 

Steel Eagle Holdings, Inc

Dull Investment Corporation

Sharp Clinical Services Incorporated

Sharp Corporation

Ashfield Healthcare Communications, LLC

Ballina Pharma Inc

Magna Healthcare Inc

Ashfield Healthcare LLC

UDG Healthcare Limited

UDG Healthcare UK (Holdco) Limited

Mantis Surgical Limited

Mediscope Limited

Barclay (Northern Ireland) Limited

Klondyke Enterprises Limited

Mansett Limited

Network Hospital Services Limited

Robert Smith & Co. (Derry) Limited

Vector Scientific Limited

Intraveno (N.I.) Limited

New Splint Limited

Unitech Equipment Limited

TD Packaging Limited

Ashfield Alliance Limited

Ashfield Healthcare (Ireland) Limited

Dublin Drug (Investments) Limited

Dublin Drug Company Limited

Dublin Drug Public Limited Company

Dugdale Trading Limited

Marker (U.D.) Ireland Limited

Oremelt Company Unlimited Company

Pharmexx Ireland (Sales Solutions) Limited

UDG Healthcare Ayrtons (Dublin) Limited

UDG Healthcare Finance Limited

UDG Healthcare Ireland Limited

UDG Healthcare Nordic Limited

UDG Healthcare Packaging Group Limited

UDG Healthcare Property Holdings Limited

United Care Limited

Aquilant Analytical Sciences Limited

Aquilant Endoscopy Limited

Aquilant Limited

Aquilant Medical (ROI) Limited

Aquilant Nederland B.V.

Aquilant Northern Ireland Limited

Aquilant Pharmaceuticals Limited

Aquilant Scientific (ROI) Limited

UDG Healthcare Specialist Product Services Limited

Alchem Plc

Pemberton Marketing Limited

Magir Limited

UDG Healthcare Distributors Limited

The Health Insurance Authority

Marker International BV

Magna Finance BV

UniDrug Distribution Group Limited

 

ENDS

 

 

 

 

 

 

Enquiries:

 

Peter Dunne +353 (0)1 563 4965

Company Secretary

Origin Enterprises plc

 

Davy (Nominated Adviser)

Anthony Farrell + 353 (0)1 614 9993

 

 

About Origin Enterprises plc

Origin Enterprises plc is a focused Agri-Services group providing specialist On-Farm Agronomy Services, Digital Agricultural Services and the supply of crop technologies and inputs. The Group has leading market positions in Ireland, the United Kingdom, Belgium, Brazil, Poland, Romania and Ukraine. Origin is listed on the ESM and AIM markets of the Irish and London Stock Exchanges.

 

ESM ticker symbol: OIZ

AIM ticker symbol: OGN

 

Website: www.originenterprises.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRBUBDGSUGBGIB
Date   Source Headline
30th Jan 20247:00 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
19th Jan 202412:31 pmRNSRe-issue of Treasury Shares
15th Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
5th Jan 202412:38 pmRNSRe-issue of Treasury Shares
5th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSTransaction in Own Shares
19th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20237:00 amRNSTransaction in Own Shares
15th Dec 20231:28 pmRNSRe-issue of Treasury Shares
15th Dec 20237:00 amRNSTransaction in Own Shares
14th Dec 20237:00 amRNSTransaction in Own Shares
13th Dec 20237:00 amRNSTransaction in Own Shares
12th Dec 20237:00 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSTransaction in Own Shares
8th Dec 20237:00 amRNSTransaction in Own Shares
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 202312:20 pmRNSRe-issue of Treasury Shares
1st Dec 20237:00 amRNSTransaction in Own Shares
30th Nov 20232:28 pmRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
23rd Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20234:33 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTransaction in Own Shares
21st Nov 20234:05 pmRNSHolding(s) in Company
21st Nov 20231:20 pmRNSDirector/PDMR Shareholding
20th Nov 20237:00 amRNSEUR20 Million Share Buyback Programme
17th Nov 202312:43 pmRNSRe-issue of Treasury Shares
16th Nov 20235:01 pmRNSAnnual General Meeting
16th Nov 20237:00 amRNSQ1 FY24 Trading Update
9th Nov 20237:00 amRNSClimate action targets validated by SBTi

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.